Previous 10 | Next 10 |
2023-06-14 14:36:53 ET InMode ( NASDAQ: INMD ) ticked up 0.5% amid a positive mention from an investor about the aesthetics company. InMode ( INMD ) was pitched by Aureus Asset Management's Karen Firestone as a "final trade" on CNBC's "Halftime" show. "There are a...
2023-06-06 23:47:13 ET Summary InMode is a leader in the niche industry of minimally invasive medical treatment solutions, with strong brand recognition and a growing market presence. The company has an experienced leadership team, impressive financials, including high gross margi...
2023-06-05 11:00:00 ET Summary InMode stock has underperformed the S&P 500 significantly since our previous update, as we urged investors to be cautious. INMD has failed to clear the $40 resistance level decisively since August 2022. Its tepid forward guidance indicates that t...
2023-05-24 13:57:04 ET The Russell 3000 index will have a new look on June 26, after the market opens, when 286 securities will be added and 179 securities will be deleted as part of the annual reconstitution. Following are some notable healthcare companies which will be added an...
2023-05-18 09:30:00 ET Are you looking for a stock to buy that's generating strong growth and trading at a low valuation? It's not easy to find that combination given the current economic conditions, but one that could fit the bill is InMode (NASDAQ: INMD) . The business has bee...
InMode to Present at Upcoming Investor Conferences and Events PR Newswire YOKNEAM, Israel , May 17, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that InMode will participate at ...
2023-05-10 05:30:00 ET Teladoc Health (NYSE: TDOC) and InMode (NASDAQ: INMD) both operate in high-growth industries. Teladoc is a leader in telemedicine. InMode specializes in selling devices in the minimally invasive and non-invasive aesthetics market. Both of these areas a...
2023-05-07 05:17:00 ET Are you looking for underappreciated growth stocks that can deliver big gains? Try starting your search in the rapidly growing industry for minimally invasive cosmetic procedures. The global market for noninvasive aesthetic treatments reached $61.2 billion in 2022...
2023-05-05 23:26:46 ET Summary InMode is a leading provider of innovative, energy-based, and minimally invasive aesthetic and medical treatment solutions. The company has seen explosive growth on both the top line and bottom line with revenues and EBITDA growing at a 46% and ...
2023-05-02 18:30:33 ET The stock of medical aesthetics tech company InMode (NASDAQ: INMD) wasn't looking very pretty on Tuesday. The company published its latest set of quarterly figures, and some investors found them sorely wanting. In consequence the share price took a 10% hit on ...
News, Short Squeeze, Breakout and More Instantly...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Oppo...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...